Meng XD, Tong Y, Wei ZN, Wang L, Mai JY, Wu Y, Luo ZY, Li S, Li M, Wang S, Wei S, Gong W, Zhang W, Hu X, Huang J, Shi J, Yang G, Meng S, Wang Z, Guan X, Shen S. Epidemical and etiological study on hand, foot and mouth disease following EV-A71 vaccination in Xiangyang. China Sci Rep. 2020;10:20909.

Article  CAS  PubMed  Google Scholar 

Liu F, Ren M, Chen S, Nie T, Cui J, Ran L, Li Z, Chang Z. Pathogen spectrum of hand, foot, and mouth disease based on laboratory surveillance - China, 2018. China CDC Wkly. 2020;2:167–71.

Article  PubMed  PubMed Central  Google Scholar 

Zhu P, Ji W, Li D, Li Z, Chen Y, Dai B, Han S, Chen S, Jin Y, Duan G. Current status of hand-foot-and-mouth disease. J Biomed Sci. 2023;30:15.

Article  PubMed  PubMed Central  Google Scholar 

Wang J, Zhou J, Xie G, Zheng S, Lou B, Chen Y, Wu Y. The epidemiological and clinical characteristics of hand, foot, and mouth disease in hangzhou, China, 2016 to 2018. Clin Pediatr (Phila). 2020;59:656–62.

Article  PubMed  Google Scholar 

Ho JY, Chern JH, Hsieh CF, Liu ST, Liu CJ, Wang YS, Kuo TW, Hsu SJ, Yeh TK, Shih SR, Hsieh PW, Chiu CH, Horng JT. In vitro and in vivo studies of a potent capsid-binding inhibitor of enterovirus 71. J Antimicrob Chemother. 2016;71:1922–32.

Article  CAS  PubMed  Google Scholar 

Chen SG, Cheng ML, Chen KH, Horng JT, Liu CC, Wang SM, Sakurai H, Leu YL, Wang SD, Ho HY. Antiviral activities of Schizonepeta tenuifolia Briq. against enterovirus 71 in vitro and in vivo. Sci Rep. 2017;7:935.

Article  PubMed  PubMed Central  Google Scholar 

Deng CL, Yeo H, Ye HQ, Liu SQ, Shang BD, Gong P, Alonso S, Shi PY, Zhang B. Inhibition of enterovirus 71 by adenosine analog NITD008. J Virol. 2014;88:11915–23.

Article  PubMed  PubMed Central  Google Scholar 

Minor PD. The molecular biology of poliovaccines. J Gen Virol. 1992;73(Pt 12):3065–77.

Article  CAS  PubMed  Google Scholar 

Kitamura N, Semler BL, Rothberg PG, Larsen GR, Adler CJ, Dorner AJ, Emini EA, Hanecak R, Lee JJ, van der Werf S, Anderson CW, Wimmer E. Primary structure, gene organization and polypeptide expression of poliovirus RNA. Nature. 1981;291:547–53.

Article  CAS  PubMed  Google Scholar 

Wang X, Ku Z, Zhang X, Ye X, Chen J, Liu Q, Zhang W, Zhang C, Fu Z, Jin X, Cong Y, Huang Z. Structure, immunogenicity, and protective mechanism of an engineered Enterovirus 71-like particle vaccine mimicking 80S empty capsid. J Virol. 2017;92:e01330-e1417.

PubMed  PubMed Central  Google Scholar 

Lyu K, He YL, Li HY, Chen R. Crystal structures of yeast-produced Enterovirus 71 and Enterovirus 71/Coxsackievirus A16 chimeric virus-like particles provide the structural basis for novel vaccine design against hand-foot-and-mouth disease. J Virol. 2015;89:6196–208.

Article  PubMed  PubMed Central  Google Scholar 

Minor PD, Ferguson M, Evans DM, Almond JW, Icenogle JP. Antigenic structure of polioviruses of serotypes 1, 2 and 3. J Gen Virol. 1986;67:1283–91.

Article  CAS  PubMed  Google Scholar 

Jin WP, Lu J, Zhang XY, Wu J, Wei ZN, Mai JY, Qian SS, Yu YT, Meng SL, Wang ZJ, Shen S. Efficacy of Coxsackievirus A5 vaccine candidates in an actively immunized mouse model. J Virol. 2021;95:e01743-e1820.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Xu L, Zheng Q, Li S, He M, Wu Y, Li Y, Zhu R, Yu H, Hong Q, Jiang J, Li Z, Li S, Zhao H, Yang L, Hou W, Wang W, Ye X, Zhang J, Baker TS, Cheng T, Zhou ZH, Yan X, Xia N. Atomic structures of Coxsackievirus A6 and its complex with a neutralizing antibody. Nat Commun. 2017;8:505.

Article  PubMed  PubMed Central  Google Scholar 

Zhu R, Xu L, Zheng Q, Cui Y, Li S, He M, Yin Z, Liu D, Li S, Li Z, Chen Z, Yu H, Que Y, Liu C, Kong Z, Zhang J, Baker TS, Yan X, Hong Zhou Z, Cheng T, Xia N. Discovery and structural characterization of a therapeutic antibody against coxsackievirus A10. Sci Adv. 2018;4:eaat7459.

Article  PubMed  PubMed Central  Google Scholar 

Organtini LJ, Makhov AM, Conway JF, Hafenstein S, Carson SD. Kinetic and structural analysis of coxsackievirus B3 receptor interactions and formation of the A-particle. J Virol. 2014;88:5755–65.

Article  PubMed  PubMed Central  Google Scholar 

Lim XF, Jia Q, Khong WX, Yan B, Premanand B, Alonso S, Chow VT, Kwang J. Characterization of an isotype-dependent monoclonal antibody against linear neutralizing epitope effective for prophylaxis of enterovirus 71 infection. PLoS ONE. 2012;7: e29751.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chen J, Zhang C, Zhou Y, Zhang X, Shen C, Ye X, Jiang W, Huang Z, Cong Y. A 3.0-Angstrom resolution cryo-electron microscopy structure and antigenic sites of Coxsackievirus A6-like particles. J Virol. 2018;92:0125717.

Article  Google Scholar 

Fu L, Zhang XY, Jin WP, Wang C, Qian SS, Wang MJ, Wang WH, Meng SL, Guo J, Wang ZJ, Chen XQ, Shen S. Identification of a conserved, linear epitope on VP3 of Enterovirus A species recognized by a broad-spectrum monoclonal antibody. Viruses. 2023;15:1028.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hu G, Jin WP, Yang ZH, Lv SY, Wu J, Yu YT, Meng SL, Guo J, Wang ZJ, Shen S. Efficacy of Coxsackievirus A2 vaccine candidates correlating to humoral immunity in mice challenged with a mouse-adapted strain. Vaccine. 2022;40:4716–25.

Article  CAS  PubMed  Google Scholar 

An HH, Li M, Liu RL, Wu J, Meng SL, Guo J, Wang ZJ, Qian SS, Shen S. Humoral and cellular immunogenicity and efficacy of a coxsackievirus A10 vaccine in mice. Emerg Microbes Infect. 2023;12: e2147022.

Article  PubMed  PubMed Central  Google Scholar 

Fox H, Knowlson S, Minor PD, Macadam AJ. Genetically thermo-stabilised, immunogenic poliovirus empty capsids; a strategy for non-replicating vaccines. PLoS Pathog. 2017;13: e1006117.

Article  PubMed  PubMed Central  Google Scholar 

Martín J, Crossland G, Wood DJ, Minor PD. Characterization of formaldehyde-inactivated poliovirus preparations made from live-attenuated strains. J Gen Virol. 2003;84:1781–8.

Article  PubMed  Google Scholar 

Singer C, Knauert F, Bushar G, Klutch M, Lundquist R, Quinnan GV Jr. Quantitation of poliovirus antigens in inactivated viral vaccines by enzyme-linked immunosorbent assay using animal sera and monoclonal antibodies. J Biol Stand. 1989;17:137–50.

Article  CAS  PubMed  Google Scholar 

van Steenis G, van Wezel AL, Sekhuis VM. Potency testing of killed polio vaccine in rats. Dev Biol Stand. 1981;47:119–28.

PubMed  Google Scholar 

Trabelsi A, Grattard F, Nejmeddine M, Aouni M, Bourlet T, Pozzetto B. Evaluation of an enterovirus group-specific anti-VP1 monoclonal antibody, 5–D8/1, in comparison with neutralization and PCR for rapid identification of enteroviruses in cell culture. J Clin Microbiol. 1995;33(9):2454–7.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yousef GE, Brown IN, Mowbray JF. Derivation and biochemical characterization of an enterovirus group-specific monoclonal antibody. Intervirology. 1987;28(3):163–70.

Article  CAS  PubMed  Google Scholar 

Tian YX, Jin WP, Wei ZN, Lv SY, Wang MJ, Meng SL, Guo J, Wang ZJ, Shen S. Identification of specific and shared epitopes at the extreme N-terminal VP1 of Coxsackievirus A4, A2 and A5 by monoclonal antibodies. Virus Res. 2023;328: 199074.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Thanongsaksrikul J, Srimanote P, Tongtawe P, Glab-Ampai K, Malik AA, Supasorn O, Chiawwit P, Poovorawan Y, Chaicumpa W. Identification and production of mouse scFv to specific epitope of enterovirus-71 virion protein-2 (VP2). Arch Virol. 2018;163:1141–52.

Article  CAS  PubMed  Google Scholar 

Phanthong S, Densumite J, Seesuay W, Thanongsaksrikul J, Teimoori S, Sookrung N, Poovorawan Y, Onvimala N, Guntapong R, Pattanapanyasat K, Chaicumpa W. Human antibodies to VP4 inhibit replication of Enteroviruses across subgenotype